| Rebif (human IFN-β-1a) / EMD Serono |
| Completed | 1 | 24 | Europe | Interferon beta-1a HSA-free biosimilar, Bioferon®, Interferon beta-1a HSA+ biosimilar, Interferon beta-1a original, Rebif® | Centre Hospitalier Universitaire Vaudois, BioPartners GmbH | Multiple Sclerosis, Relapsing-Remitting | 07/06 | 07/06 | | |
NCT00618527: Combination Therapy Using Cellcept and Rebif in RRMS |
|
|
| Completed | 1 | 31 | US | mycophenolate mofetil (Cellcept), Cellcept, human interferon beta 1a (Rebif), Rebif | Aaron Boster, EMD Serono, Pfizer | Multiple Sclerosis | 05/12 | 05/12 | | |
| Completed | 1 | 23 | US | ACTH, Acthar Gel, Methylprednisolone, Solumedrol | University of Southern California | Multiple Sclerosis | 06/13 | 07/13 | | |
NCT02269930: Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers |
|
|
| Completed | 1 | 30 | US | peginterferon beta-1a, BIIB017, Plegridy, Rebif | Biogen | Multiple Sclerosis | 12/14 | 12/14 | | |
